Serotonin 5-HT5 Receptor Neurons

Serotonin 5-HT5 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Serotonin 5-HT5 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Serotonin Receptor Neurons</td>
</tr>
<tr>
<td class="label">Primary Receptor</td>
<td>5-HT5A (encoded by HTR5A gene), 5-HT5B (encoded by HTR5B gene)</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HTR5A, HTR5B</td>
</tr>
<tr>
<td class="label">Signal Transduction</td>
<td>Gi/o protein-coupled inhibition of adenylate cyclase</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Cortex, hippocampus, cerebellum, thalamus, hypothalamus</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Neuronal (primarily postsynaptic), some presynaptic</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">5-HT5A</td>
<td>HTR5A</td>
</tr>
<tr>
<td class="label">5-HT5B</td>

Serotonin 5-HT5 Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Serotonin 5-HT5 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Serotonin Receptor Neurons</td>
</tr>
<tr>
<td class="label">Primary Receptor</td>
<td>5-HT5A (encoded by HTR5A gene), 5-HT5B (encoded by HTR5B gene)</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>HTR5A, HTR5B</td>
</tr>
<tr>
<td class="label">Signal Transduction</td>
<td>Gi/o protein-coupled inhibition of adenylate cyclase</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Cortex, hippocampus, cerebellum, thalamus, hypothalamus</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Neuronal (primarily postsynaptic), some presynaptic</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Subtype</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">5-HT5A</td>
<td>HTR5A</td>
</tr>
<tr>
<td class="label">5-HT5B</td>
<td>HTR5B</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Pyramidal neuron inhibition</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>LTP) modulation</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Purkinje cell regulation</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Sensory gating</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Type</td>
</tr>
<tr>
<td class="label">SB-699551</td>
<td>Antagonist</td>
</tr>
<tr>
<td class="label">SB-699551-2</td>
<td>Antagonist</td>
</tr>
<tr>
<td class="label">AS-2038920</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">A-843277</td>
<td>Antagonist</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Radioligand binding</td>
<td>Receptor density measurement</td>
</tr>
<tr>
<td class="label">Immunohistochemistry</td>
<td>Protein localization</td>
</tr>
<tr>
<td class="label">In situ hybridization</td>
<td>mRNA distribution</td>
</tr>
<tr>
<td class="label">Knockout mice</td>
<td>Functional studies</td>
</tr>
<tr>
<td class="label">Conditional knockout</td>
<td>Cell-type specific deletion</td>
</tr>
<tr>
<td class="label">RNA sequencing</td>
<td>Expression profiling</td>
</tr>
</table>

Serotonin 5 Ht5 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The serotonin 5-HT5 receptor represents one of the most enigmatic members of the serotonin receptor family, with the least understood physiological functions. These inhibitory GPCRs are expressed in brain regions critical for cognition, mood, and sleep regulation. Despite their discovery decades ago, 5-HT5 receptors have remained relatively understudied compared to other serotonin receptor subtypes, making them an intriguing target for future therapeutic development in neurological and psychiatric disorders. [@sommer2006]

Overview

<!-- multi-taxonomy-enrichment -->

<!-- taxonomy-enrichment -->

Taxonomy & Classification

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Biology

Receptor Genes and Structure

The 5-HT5 receptor family consists of two subtypes:

Structural Features:

• Seven transmembrane domains typical of Class A GPCRs
• Conserved DRY motif at intracellular loop 3
• Disulfide bond between Cys residues in extracellular loops
• N-linked glycosylation sites in N-terminal domain

Signaling Pathways

5-HT5 receptors couple primarily to Gi/o proteins:

Ligand Binding

• Endogenous ligand: Serotonin (5-HT)
• High affinity for serotonin (nanomolar range)
• Limited selective ligands available due to undercharacterization

Neuroanatomy

Regional Distribution

5-HT5 receptor expression in the human brain:

Cerebral Cortex:

• Layer I-V pyramidal neurons
• GABAergic interneurons
• Highest cortical density in frontal and parietal lobes

• CA1 pyramidal neurons
• Dentate gyrus granule cells
• Interneurons in strata radiatum and lacunosum-moleculare

• Purkinje cells
• Granule cell layer
• Deep cerebellar nuclei

• Thalamus (intralaminar nuclei)
• Hypothalamus (paraventricular nucleus)
• Basal ganglia (caudate, putamen)

Cellular Localization

• Postsynaptic: Primary location on dendritic shafts and spines
• Presynaptic: Lower density on axon terminals
• Somatic: Moderate expression on cell bodies
• Non-neuronal: Limited expression on astrocytes

Neurophysiology

Inhibitory Signaling

5-HT5 receptors mediate inhibitory neurotransmission:

Modulation of Neural Circuits

Clinical Significance

Sleep Disorders

5-HT5 receptors play important roles in sleep architecture[@stocker2023]:

• Sleep regulation: 5-HT5A modulates REM and non-REM sleep through hypothalamic and brainstem circuits
• Circadian rhythm: Interaction with suprachiasmatic nucleus affects circadian entrainment
• Insomnia: Potential therapeutic target given serotonergic involvement in sleep initiation
• Sleep homeostasis: Regulation of sleep pressure through thalamic signaling

Migraine

• 5-HT5 receptors located on cerebral vasculature and trigeminal neurons
• Vascular tone modulation through smooth muscle effects
• Pain signaling in trigeminal pathway and central pain processing
• Therapeutic potential for acute migraine treatment remains exploratory

Cognitive Disorders

5-HT5 receptors in cognitive function[@heidbrecht2021][@geyer2019]:

• Memory function: 5-HT5A in hippocampal plasticity and consolidation
• Learning: Role in aversive and spatial learning paradigms
• Alzheimer's disease: Reduced expression in AD brains correlates with cognitive decline
• Therapeutic potential: 5-HT5 antagonists may enhance cognition through disinhibition

Depression and Anxiety

5-HT5 receptor involvement in mood disorders[@gustafsson2005]:

• 5-HT system widely implicated in mood regulation
• Limited data on 5-HT5 specifically in depression
• Interaction with 5-HT1A and 5-HT2C receptors in affective circuits
• Novel antidepressant potential remains to be validated

Schizophrenia

5-HT5 receptors in psychosis[@nagai2007]:

• 5-HT5A binding altered in postmortem schizophrenia brain
• Cognitive symptoms may involve 5-HT5-mediated prefrontal dysfunction
• Interaction with dopaminergic and glutamatergic systems
• Research ongoing to determine therapeutic relevance

Research and Therapeutic Development

Selective Ligands

Challenges in Drug Development

• Limited understanding of physiological functions
• Few selective ligands available
• Species differences in receptor pharmacology
• Brain penetration requirements
• Receptor dimerization complexity

Neurodegeneration

Alzheimer's Disease

• 5-HT5A expression reduced in AD hippocampus
• Amyloid-beta affects 5-HT5 signaling
• Cognitive decline correlates with receptor loss
• Therapeutic potential for cognition enhancement

Parkinson's Disease

• 5-HT5 receptors on serotonergic terminals
• Interaction with dopaminergic system
• L-DOPA-induced dyskinesias may involve 5-HT5
• Sleep disorders in PD benefit from modulation

Multiple Sclerosis

• 5-HT5 expression on immune cells
• Inflammatory modulation possible
• Myelin repair research ongoing
• Fatigue in MS may involve serotonergic system

Research Methods

Experimental Approaches

Animal Models

• HTR5A-/- mice: Constitutive knockout
• HTR5B-/- mice: Subtype-specific deletion
• Double knockout: Combined deletion
• Humanized mice: Translational research

Future Directions

Knowledge Gaps

• Physiological functions remain poorly understood
• Therapeutic indications not established
• Receptor heteromers not characterized
• Signal transduction bias not defined

Research Priorities

• Selective tool compounds development
• Physiological role elucidation
• Disease involvement characterization
• Clinical trials for novel indications
• Serotonin 5-HT1A Receptor Neurons
• Serotonin 5-HT2A Receptor Neurons
• Serotonin Neurotransmission
• Serotonin Receptors
• Hippocampal CA1 Neurons
• Cerebellar Purkinje Cells
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Migraine
• Insomnia
• HTR5A Gene
• HTR5B Gene

Background

The study of Serotonin 5 Ht5 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

See Also

• [PINK1 Protein](/wiki/proteins-pink1) — modulates
• [PRKN — Parkin RBR E3 Ubiquitin Protein Ligase](/wiki/genes-prkn) — modulates
• [Hippocampus](/wiki/brain-regions-hippocampus) — active_in
• [Neurons in Dentatorubral-Pallidoluysian Atrophy](/wiki/cell-types-dentatorubral-pallidoluysian-atrophy-neurons) — released_by

Pathway Diagram

The following diagram shows the key molecular relationships involving Serotonin 5-HT5 Receptor Neurons discovered through SciDEX knowledge graph analysis: